This study was conducted at Gencare Incorporated resident facilities in the Pacific Northwest looking at the effects of different activities on the quality of life in seniors.
This randomized, placebo-controlled trial was conducted to determine the effect of oral GSH supplementation on systemic markers of oxidative stress (F2-isoprostanes, 8-hydroxy-2'-deoxyguanosine (8-OHdG)), in healthy adult volunteers (N=40), as well as changes in red blood.
This pilot trial tests the feasibility and effectiveness of the naturopathic diet as it compares to standard conventional dietary education. Preliminary data will be used to determine if a naturopathic diet improves glycemic control, quality of life, and nutritional knowledge outcomes.
The objective is to improve the quality of patient dying and death by the use of integrative medicine using mind, body, and energy interventions to complement allopathic comfort care for persons with advanced cancer and AIDS.
Data from multiple epidemiologic and clinical studies on immune effects of conventional cancer treatment and the clinical benefits of polysaccharide immune therapy suggest that immune function has a role in breast cancer prevention.
This article reviews the evidence that the functioning of both the innate and the adaptive immune system plays a role in preventing relapse in women with breast cancer.
Characteristics of naturopathic physicians most interested in active pediatric research involvement included fewer years in practice, greater number of pediatric patients treated per week, and having shared office space.
In this study, use of H. perforatum for treatment of ADHD over the course of 8 weeks did not improve symptoms.
Complementary and alternative medicine is either empowering or has empowered patients to use CAM. People who use CAM may have a better prognosis and better management of chronic conditions.
Patients did not report significant fatigue levels for the 6 weeks after completing RT. Significant decreases in the numbers and functions of cells from both the innate and adaptive immune system were detected following a standard course of radiation therapy for the treatment of breast cancer. Immune deficits in lymphocyte populations and TNF-alpha production, should they persist, may have consequences for immune response to residual or recurrent malignancy following completion of conventional treatment. The use of adjunctive immune therapies which target these specific defects may be warranted in the post-treatment period.